David A. Siegel Petros Pharmaceuticals, Inc. Transaction History

Two Sigma Advisers, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.68 - $1.49 $50,184 - $109,962	-73,800 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.07 - $3.36 $66,126 - $207,648	61,800 Added 515.0%	73,800 $115,000
Q4 2021 Feb 14, 2022	BUY	$1.33 - $4.09 $15,960 - $49,080	12,000 New	12,000 $40,000

Ticker PTPI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 20,708,000
Market Cap $7.04M
Description
Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a patented topical formulation candidate for th...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.